查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830736

2025年化学冷光免疫检测全球市场报告

Chemiluminescence Immunoassay Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，化学冷光免疫检测市场规模强劲成长，从2024年的136.3亿美元增加至2025年的148.5亿美元，复合年增长率为8.9%。预测期内的增长可归因于对高灵敏度检测技术的日益关注、化学冷光分析与就地检验设备的日益融合、对多重检测能力的需求不断增长、化学冷光在肿瘤诊断中的应用不断扩大以及感染疾病的流行率不断上升。

预计未来几年化学冷光免疫检测市场规模将强劲成长，到2029年将达到206.4亿美元，复合年增长率为8.6%。预测期内的成长可归因于个人化医疗需求的不断增长、数位医疗技术的日益普及、医疗基础设施投资的不断增加、感染疾病诊断应用的不断扩展以及自动化中心实验室环境的不断发展。这段时期的主要趋势包括：自动化免疫检测平台的演进、多重化学冷光免疫检测技术的开发、照护现场解决方案的创新、人工智慧在结果解读中的应用集成，以及化学化学冷光免疫检测在个人化医疗中的日益广泛的应用。

化学冷光免疫检测(CLIA) 是一种生化技术，可透过将抗原-抗体相互作用与化学冷光讯号结合，用于检测和定量特定分子，例如蛋白质、荷尔蒙和病原体。此方法透过测量化学反应过程中产生的光来确定目标分析物的存在和浓度。它能够进行灵敏、特异性且快速的诊断检测，并广泛应用于临床和研究领域。

化学冷光免疫检测的主要产品类型包括分析仪、套件和试剂。分析仪是一种自动化设备，透过检测和测量反应过程中发出的光来进行化学发光免疫分析 (CLIA) 检测。这些系统相容于多种样本类型，包括血液、唾液和尿液，并采用不同的技术，包括化学冷光酵素免疫分析法(CLEIA)、化学冷光免疫检测(ECLI)和微粒化学化学冷光免疫检测。 CLIA 应用包括治疗药物监测、肿瘤学、心臟病学、内分泌学、感染疾病和循环系统疾病，服务于广泛的最终用户，包括医院、製药公司、生物技术公司和临床实验室。

2025年春季美国突然提高关税以及由此引发的贸易摩擦对医疗保健产业产生了严重影响，特别是对关键医疗设备、诊断设备和药品的供应。医院和医疗机构面临进口手术器械、影像设备以及注射器和导管等消耗品成本上涨的问题。这些成本上涨给医疗保健预算带来了压力，导致一些医疗机构推迟设备升级或将成本转嫁给患者。此外，原料和零件的关税阻碍了基本药品和医疗设备的生产，造成了供应链瓶颈。作为应对措施，该行业正在筹资策略多样化，尽可能促进本地生产，并倡导对紧急医疗产品免关税。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供化学冷光免疫检测分析市场统计数据，例如全球市场规模、区域份额、竞争对手的化学冷光免疫检测分析市场份额、详细的化学冷光免疫检测市场细分、市场趋势和机会，以及您在化学冷光化学冷光免疫检测化学冷光免疫检测对该行业的现状和未来趋势进行了详细分析，为您提供免疫检测的一切观点。

预计感染疾病的日益普及将在未来几年推动化学冷光免疫检测市场的成长。感染疾病是由细菌、病毒、真菌和寄生虫等有害微生物引起的疾病，可在人与人之间直接或间接传播。抗生素抗药性的上升加剧了这一趋势，因为它降低了常用治疗方法的有效性，并使感染疾病持续存在和蔓延。化学冷光免疫测量透过灵敏和特异性的生物标记检测来支持感染疾病的诊断，从而能够及早准确地识别病原体。这些检测有助于减少诊断延迟、改善患者管理并提高治疗效果。例如，2024 年 2 月，英国卫生安全局报告称，到 2023 年，英格兰的结核病病例将增加到 4,850 例，比 2022 年的 4,380 例增加 10.7%。因此，感染疾病的日益普及正在推动对化学冷光免疫检测的需求。

化学冷光免疫检测市场的主要参与者正在开发先进产品，例如高性能化学冷光免疫检测分析仪，以提高诊断准确性、增加通量并在各种临床应用中快速提供结果。这些分析仪可自动检测和测量化学反应过程中发出的光，以准确识别特定的生物标记。例如，2023 年 7 月，中国生物技术公司 Fapon Biotech Inc. 推出了 Shine i8000/9000 分析仪。它专为中大型实验室设计，可在 10 分钟内提供初步结果，并以紧凑、用户友好的设计提供高精度。主要功能包括大型 360 度显示器、一键式批量装载反应杯、双管备用基材系统以及自动反应杯处理以最大限度地减少污染。全自动工作流程减少了人工，先进的演算法确保了一致的结果，使其成为大容量诊断环境的理想选择。

2023年12月，美国生命科学和诊断公司丹纳赫集团（Danaher Corporation）以约57亿美元收购了Abcam Limited。此次收购增强了丹纳赫生命科学部门的实力，使其能够利用Abcam经过验证的抗体、试剂、生物标记和检测方法，加速药物研发和疾病谱分析，同时使Abcam能够独立运作。 Abcam Limited是一家总部位于英国的生命科学公司，专注于化学冷光免疫检测套件和试剂。

化学冷光免疫检测市场由提供高灵敏度诊断测试、疾病生物标记检测、临床实验室工作流程优化和个人化医疗诊断等服务的营业单位获得的收益所构成。市场价值还包括服务供应商销售或包含在其服务产品中的相关产品的价值。化学冷光免疫检测市场包括用于执行基于化学冷光的诊断测试的免疫检测分析仪、控制和校准溶液、诊断耗材以及相关配件的销售。该市场中的商品价值为“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球化学冷光免疫检测：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球化学冷光免疫检测市场：成长率分析
  • 全球化学冷光免疫检测市场表现：规模与成长，2019-2024
  • 全球化学冷光免疫检测市场预测：规模与成长，2024-2029年，2034年
  • 全球化学冷光免疫检测：总潜在市场（TAM）

第六章 市场细分

  • 全球化学冷光免疫检测市场：依产品类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 分析器
  • 套件
  • 试剂
  • 全球化学冷光免疫检测市场（按样本类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 血
  • 唾液
  • 尿
  • 其他样品
  • 全球化学冷光免疫检测市场：依技术、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 化学冷光酶技术（CLEIA）
  • 化学冷光免疫检测（ECLI）
  • 微粒化学化学冷光免疫检测
  • 全球化学冷光免疫检测市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 治疗药物监测
  • 肿瘤学
  • 心臟病学
  • 内分泌学
  • 感染疾病
  • 自体免疫疾病
  • 其他用途
  • 全球化学冷光免疫检测市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 製药和生物技术公司
  • 临床实验室
  • 其他最终用户
  • 全球化学冷光免疫检测市场：按分析仪类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 全自动分析仪
  • 半自动分析仪
  • 可携式分析仪
  • 全球化学冷光免疫检测市场：套件类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 检测试剂套件
  • 定量试剂套件
  • 定性试剂套件
  • 多参数套件
  • 全球化学冷光免疫检测市场：按试剂类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 鲁米诺试剂
  • 异鲁米诺试剂
  • 吖啶酯试剂
  • 其他试剂

第七章 区域和国家分析

  • 全球化学冷光免疫检测市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球化学冷光免疫检测市场：依国家/地区、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 化学冷光免疫检测市场：竞争格局
  • 化学冷光免疫检测市场：公司简介
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • QuidelOrtho Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Revvity Inc.
  • DiaSorin SpA
  • Tecan Group Ltd.
  • Euroimmun AG
  • Randox Laboratories Ltd.
  • Autobio Diagnostics Co. Ltd.
  • Wondfo Biotech Co. Ltd.
  • Fujirebio Diagnostics Inc.
  • Trivitron Healthcare Pvt. Ltd.
  • Getein Biotech Inc.
  • Fapon Biotech Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年化学冷光免疫检测市场：提供新机会的国家
  • 2029年化学冷光免疫检测市场：细分领域带来新机会
  • 2029年化学冷光免疫检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r37723

Chemiluminescence immunoassay (CLIA) is a biochemical technique used to detect and quantify specific molecules, such as proteins, hormones, or pathogens, by combining antigen-antibody interactions with a chemiluminescent signal. In this method, light generated during a chemical reaction is measured to determine the presence and concentration of the target analyte. It offers highly sensitive, specific, and rapid diagnostic testing for both clinical and research applications.

The main product categories in chemiluminescence immunoassay include analyzers, kits, and reagents. Analyzers are automated instruments designed to perform CLIA tests by detecting and measuring the emitted light during the reaction. These systems handle various sample types, such as blood, saliva, urine, and others, and employ different technologies, including chemiluminescence enzyme immunoassay (CLEIA), electrochemiluminescence immunoassay (ECLI), and microparticle chemiluminescence immunoassay. CLIA finds applications in therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious diseases, autoimmune disorders, and more, serving a wide range of end users including hospitals, pharmaceutical and biotech companies, and clinical laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The chemiluminescence immunoassay market research report is one of a series of new reports from The Business Research Company that provides chemiluminescence immunoassay market statistics, including chemiluminescence immunoassay industry global market size, regional shares, competitors with a chemiluminescence immunoassay market share, detailed chemiluminescence immunoassay market segments, market trends and opportunities, and any further data you may need to thrive in the chemiluminescence immunoassay industry. This chemiluminescence immunoassay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chemiluminescence immunoassay market size has grown strongly in recent years. It will grow from $13.63 billion in 2024 to $14.85 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be credited to the increasing emphasis on high-sensitivity detection techniques, the expanding integration of chemiluminescence assays with point-of-care testing devices, rising demand for multiplex assay capabilities, growing use of chemiluminescence in oncology diagnostics, and the increasing prevalence of infectious diseases.

The chemiluminescence immunoassay market size is expected to see strong growth in the next few years. It will grow to $20.64 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, greater adoption of digital health technologies, rising investments in healthcare infrastructure, expanding applications in infectious disease diagnostics, and growth in automated central laboratory environments. Key trends during this period include advancements in automated immunoassay platforms, development of multiplex chemiluminescence immunoassay technologies, innovations in point-of-care diagnostic solutions, integration of AI for result interpretation, and the expanding use of chemiluminescence immunoassays in personalized medicine.

The increasing prevalence of infectious diseases is expected to drive growth in the chemiluminescence immunoassay market in the coming years. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, which can spread directly or indirectly between individuals. The rise in antimicrobial resistance is contributing to this trend, as it diminishes the effectiveness of common treatments, allowing infections to persist and spread. Chemiluminescence immunoassays support infectious disease diagnosis by providing highly sensitive and specific biomarker detection, enabling early and accurate identification of pathogens. These assays help reduce diagnostic delays, improve patient management, and enhance treatment outcomes. For instance, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England rose to 4,850 in 2023, up 10.7% from 4,380 cases in 2022. Therefore, the increasing prevalence of infectious diseases is boosting demand for chemiluminescence immunoassays.

Key players in the chemiluminescence immunoassay market are developing advanced products, such as high-performance chemiluminescence immunoassay analyzers, to improve diagnostic accuracy, increase throughput, and deliver faster results across a variety of clinical applications. These analyzers automatically detect and measure light emitted during chemical reactions to identify specific biomarkers with precision. For example, in July 2023, Fapon Biotech Inc., a China-based biotechnology company, launched the Shine i8000/9000 analyzer. Designed for medium to large laboratories, it provides preliminary results within 10 minutes and offers high precision with a compact, user-friendly design. Key features include a 360-degree large-span display, one-touch bulk loading for reaction cups, a dual-tube backup substrate system, and automatic reaction cup disposal to minimize contamination. Its fully automated workflow reduces manual intervention, while advanced algorithms ensure consistent results, making it ideal for high-volume diagnostic settings.

In December 2023, Danaher Corporation, a US-based life sciences and diagnostics company, acquired Abcam Limited for approximately \$5.7 billion. The acquisition strengthens Danaher's Life Sciences segment by leveraging Abcam's validated antibodies, reagents, biomarkers, and assays to accelerate drug discovery and disease mapping, while allowing Abcam to operate independently. Abcam Limited is a UK-based life sciences company specializing in chemiluminescence immunoassay kits and reagents.

Major players in the chemiluminescence immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Revvity Inc., DiaSorin S.p.A., Tecan Group Ltd., Euroimmun AG, Randox Laboratories Ltd., Autobio Diagnostics Co. Ltd., Wondfo Biotech Co. Ltd., Fujirebio Diagnostics Inc., Trivitron Healthcare Pvt. Ltd., Getein Biotech Inc., Fapon Biotech Inc., Diazyme Laboratories Inc

North America was the largest region in the chemiluminescence immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in chemiluminescence immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the chemiluminescence immunoassay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chemiluminescence immunoassay market consists of revenues earned by entities by providing services such as high-sensitivity diagnostic testing, disease biomarker detection, clinical laboratory workflow optimization, and personalized healthcare diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The chemiluminescence immunoassay market also includes sales of immunoassay analyzers, control and calibration solutions, diagnostic consumables, and related accessories used for performing chemiluminescence-based diagnostic tests. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chemiluminescence Immunoassay Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chemiluminescence immunoassay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chemiluminescence immunoassay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chemiluminescence immunoassay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Analyzers; Kits; Reagents
  • 2) By Sample Type: Blood; Saliva; Urine; Other Samples
  • 3) By Technology: Chemiluminescence Enzyme Technology (CLEIA); Electrochemiluminescence Immunoassay (ECLI); Microparticle Chemiluminescence Immunoassay
  • 4) By Application: Therapeutic Drug Monitoring; Oncology; Cardiology; Endocrinology; Infectious Disease; Autoimmune Disease; Other Applications
  • 5) By End-User: Hospitals; Pharmaceutical And Biotechnology Companies; Clinical Laboratories; Other End-Users
  • Subsegments:
  • 1) By Analyzers: Fully Automated Analyzers; Semi Automated Analyzers; Portable Analyzers
  • 2) By Kits: Detection Kits; Quantitative Kits; Qualitative Kits; Multiparameter Kits
  • 3) By Reagents: Luminol Reagents; Isoluminol Reagents; Acridinium Ester Reagents; Other Reagents
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; QuidelOrtho Corporation; Sysmex Corporation; Bio-Rad Laboratories Inc.; Revvity Inc.; DiaSorin S.p.A.; Tecan Group Ltd.; Euroimmun AG; Randox Laboratories Ltd.; Autobio Diagnostics Co. Ltd.; Wondfo Biotech Co. Ltd.; Fujirebio Diagnostics Inc.; Trivitron Healthcare Pvt. Ltd.; Getein Biotech Inc.; Fapon Biotech Inc.; Diazyme Laboratories Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chemiluminescence Immunoassay Market Characteristics

3. Chemiluminescence Immunoassay Market Trends And Strategies

4. Chemiluminescence Immunoassay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Chemiluminescence Immunoassay Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Chemiluminescence Immunoassay PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Chemiluminescence Immunoassay Market Growth Rate Analysis
  • 5.4. Global Chemiluminescence Immunoassay Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Chemiluminescence Immunoassay Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Chemiluminescence Immunoassay Total Addressable Market (TAM)

6. Chemiluminescence Immunoassay Market Segmentation

  • 6.1. Global Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Analyzers
  • Kits
  • Reagents
  • 6.2. Global Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood
  • Saliva
  • Urine
  • Other Samples
  • 6.3. Global Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chemiluminescence Enzyme Technology (CLEIA)
  • Electrochemiluminescence Immunoassay (ECLI)
  • Microparticle Chemiluminescence Immunoassay
  • 6.4. Global Chemiluminescence Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Therapeutic Drug Monitoring
  • Oncology
  • Cardiology
  • Endocrinology
  • Infectious Disease
  • Autoimmune Disease
  • Other Applications
  • 6.5. Global Chemiluminescence Immunoassay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Pharmaceutical And Biotechnology Companies
  • Clinical Laboratories
  • Other End-Users
  • 6.6. Global Chemiluminescence Immunoassay Market, Sub-Segmentation Of Analyzers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fully Automated Analyzers
  • Semi Automated Analyzers
  • Portable Analyzers
  • 6.7. Global Chemiluminescence Immunoassay Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Detection Kits
  • Quantitative Kits
  • Qualitative Kits
  • Multiparameter Kits
  • 6.8. Global Chemiluminescence Immunoassay Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Luminol Reagents
  • Isoluminol Reagents
  • Acridinium Ester Reagents
  • Other Reagents

7. Chemiluminescence Immunoassay Market Regional And Country Analysis

  • 7.1. Global Chemiluminescence Immunoassay Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Chemiluminescence Immunoassay Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chemiluminescence Immunoassay Market

  • 8.1. Asia-Pacific Chemiluminescence Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chemiluminescence Immunoassay Market

  • 9.1. China Chemiluminescence Immunoassay Market Overview
  • 9.2. China Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chemiluminescence Immunoassay Market

  • 10.1. India Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chemiluminescence Immunoassay Market

  • 11.1. Japan Chemiluminescence Immunoassay Market Overview
  • 11.2. Japan Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chemiluminescence Immunoassay Market

  • 12.1. Australia Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chemiluminescence Immunoassay Market

  • 13.1. Indonesia Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chemiluminescence Immunoassay Market

  • 14.1. South Korea Chemiluminescence Immunoassay Market Overview
  • 14.2. South Korea Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chemiluminescence Immunoassay Market

  • 15.1. Western Europe Chemiluminescence Immunoassay Market Overview
  • 15.2. Western Europe Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chemiluminescence Immunoassay Market

  • 16.1. UK Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chemiluminescence Immunoassay Market

  • 17.1. Germany Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chemiluminescence Immunoassay Market

  • 18.1. France Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chemiluminescence Immunoassay Market

  • 19.1. Italy Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chemiluminescence Immunoassay Market

  • 20.1. Spain Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chemiluminescence Immunoassay Market

  • 21.1. Eastern Europe Chemiluminescence Immunoassay Market Overview
  • 21.2. Eastern Europe Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chemiluminescence Immunoassay Market

  • 22.1. Russia Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chemiluminescence Immunoassay Market

  • 23.1. North America Chemiluminescence Immunoassay Market Overview
  • 23.2. North America Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chemiluminescence Immunoassay Market

  • 24.1. USA Chemiluminescence Immunoassay Market Overview
  • 24.2. USA Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chemiluminescence Immunoassay Market

  • 25.1. Canada Chemiluminescence Immunoassay Market Overview
  • 25.2. Canada Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chemiluminescence Immunoassay Market

  • 26.1. South America Chemiluminescence Immunoassay Market Overview
  • 26.2. South America Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chemiluminescence Immunoassay Market

  • 27.1. Brazil Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chemiluminescence Immunoassay Market

  • 28.1. Middle East Chemiluminescence Immunoassay Market Overview
  • 28.2. Middle East Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chemiluminescence Immunoassay Market

  • 29.1. Africa Chemiluminescence Immunoassay Market Overview
  • 29.2. Africa Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chemiluminescence Immunoassay Market Competitive Landscape And Company Profiles

  • 30.1. Chemiluminescence Immunoassay Market Competitive Landscape
  • 30.2. Chemiluminescence Immunoassay Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Chemiluminescence Immunoassay Market Other Major And Innovative Companies

  • 31.1. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • 31.2. QuidelOrtho Corporation
  • 31.3. Sysmex Corporation
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. Revvity Inc.
  • 31.6. DiaSorin S.p.A.
  • 31.7. Tecan Group Ltd.
  • 31.8. Euroimmun AG
  • 31.9. Randox Laboratories Ltd.
  • 31.10. Autobio Diagnostics Co. Ltd.
  • 31.11. Wondfo Biotech Co. Ltd.
  • 31.12. Fujirebio Diagnostics Inc.
  • 31.13. Trivitron Healthcare Pvt. Ltd.
  • 31.14. Getein Biotech Inc.
  • 31.15. Fapon Biotech Inc.

32. Global Chemiluminescence Immunoassay Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chemiluminescence Immunoassay Market

34. Recent Developments In The Chemiluminescence Immunoassay Market

35. Chemiluminescence Immunoassay Market High Potential Countries, Segments and Strategies

  • 35.1 Chemiluminescence Immunoassay Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Chemiluminescence Immunoassay Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Chemiluminescence Immunoassay Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer